Powchik Peter 4
4 · Vaxxinity, Inc. · Filed Oct 11, 2023
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
Powchik Peter
Director
Transactions
- Award
Stock option (right to buy)
2023-10-02+159,744→ 159,744 totalExercise: $1.27→ Class A common stock (159,744 underlying)
Footnotes (3)
- [F1]These options were granted following the Reporting Person joining the Issuer's leadership team as Executive Vice President, Global Scientific Director, effective October 1, 2023, while remaining a member of the Issuer's board of directors.
- [F2]These options vest in 12 equal monthly installments beginning on October 1, 2023.
- [F3]These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates.